Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Histopathology

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    July 2019
  1. EIRO N, Cid S, Fernandez B, Fraile M, et al
    MMP11 expression in intratumoral inflammatory cells in breast cancer.
    Histopathology. 2019 Jul 25. doi: 10.1111/his.13956.
    PubMed     Text format     Abstract available


    April 2019
  2. LEUNG SCY, Nielsen TO, Zabaglo LA, Arun I, et al
    Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration.
    Histopathology. 2019 Apr 24. doi: 10.1111/his.13880.
    PubMed     Text format     Abstract available


    March 2019
  3. LI J, Ho WY, Tsang JYS, Ni YB, et al
    Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
    Histopathology. 2019;74:567-577.
    PubMed     Text format     Abstract available


    January 2019
  4. PEKAR G, Kasselaki I, Pekar-Lukacs A, Dekany C, et al
    Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits.
    Histopathology. 2019;74:300-310.
    PubMed     Text format     Abstract available


  5. XU X, Bi R, Shui R, Yu B, et al
    Micropapillary pattern in pure mucinous carcinoma of the breast - does it matter or not?
    Histopathology. 2019;74:248-255.
    PubMed     Text format     Abstract available


    December 2018
  6. KOOPMAN T, Buikema HJ, Hollema H, de Bock GH, et al
    What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Histopathology. 2018 Dec 26. doi: 10.1111/his.13812.
    PubMed     Text format     Abstract available


  7. TSAI YF, Tseng LM, Lien PJ, Hsu CY, et al
    HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer.
    Histopathology. 2018 Dec 4. doi: 10.1111/his.13801.
    PubMed     Text format     Abstract available


    September 2018
  8. DEN BAKKER MA, Damhuis RAM
    Pentameric last-digit preference and stage border avoidance in pathology measurement.
    Histopathology. 2018;73:510-513.
    PubMed     Text format     Abstract available


    August 2018
  9. LOZADA JR, Basili T, Pareja F, Alemar B, et al
    Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
    Histopathology. 2018;73:339-344.
    PubMed     Text format     Abstract available


  10. BATAILLON G, Fuhrmann L, Girard E, Menet E, et al
    High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast.
    Histopathology. 2018;73:273-283.
    PubMed     Text format     Abstract available


    July 2018
  11. UMEKITA Y, Ohi Y, Iwaya O, Souda M, et al
    Maspin mRNA expression in sentinel lymph nodes (SLNs) predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
    Histopathology. 2018 Jul 23. doi: 10.1111/his.13718.
    PubMed     Text format     Abstract available


  12. RAKHA EA, Aleskandarany MA, Toss MS, Mongan N, et al
    Impact of Breast Cancer Grade Discordance on Prediction of Outcome.
    Histopathology. 2018 Jul 12. doi: 10.1111/his.13709.
    PubMed     Text format     Abstract available


  13. CAO L, Li C, Xu C, Xiang G, et al
    Clinical significance of PDEF factor expression and its relation to androgen receptor in ER(-) breast cancer.
    Histopathology. 2018 Jul 3. doi: 10.1111/his.13699.
    PubMed     Text format     Abstract available


  14. RAGHAVENDRA A, Kalita-de Croft P, Vargas AC, Smart CE, et al
    Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
    Histopathology. 2018;73:68-80.
    PubMed     Text format     Abstract available


    June 2018
  15. ALTHOBITI M, Aleskandarany MA, Joseph C, Toss M, et al
    Heterogeneity of Tumour Infiltrating Lymphocytes (TILs) in Breast Cancer and its prognostic significance.
    Histopathology. 2018 Jun 27. doi: 10.1111/his.13695.
    PubMed     Text format     Abstract available


  16. PUCCETTI M, Ravaioli S, Tumedei MM, Bucchi E, et al
    Are FNAB-derived cell blocks a useful surrogate for tissue samples in breast cancer?
    Histopathology. 2018 Jun 26. doi: 10.1111/his.13694.
    PubMed     Text format     Abstract available


  17. RAKHA EA, Miligy IM, Gorringe KL, Toss MS, et al
    Invasion in breast lesions: the role of the epithelial-stroma barrier.
    Histopathology. 2018;72:1075-1083.
    PubMed     Text format     Abstract available


    May 2018
  18. AFFLECK A, Lyman WB, Jacobs WC, Livasy CA, et al
    Metastatic breast cancer to the liver with hepatoid features and Hep Par 1 antibody positive mimicking hepatocellular carcinoma.
    Histopathology. 2018 May 9. doi: 10.1111/his.13644.
    PubMed     Text format     Abstract available


  19. JOSEPH C, Papadaki A, Althobiti M, Alsaleem M, et al
    Breast cancer intra-tumour heterogeneity: Current status and clinical implications.
    Histopathology. 2018 May 2. doi: 10.1111/his.13642.
    PubMed     Text format     Abstract available


    March 2018
  20. ALFARSI L, Johnston S, Liu DX, Rakha E, et al
    Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer.
    Histopathology. 2018 Mar 30. doi: 10.1111/his.13523.
    PubMed     Text format     Abstract available


  21. BULTE JP, Halilovic A, Kalkman S, van Cleef PHJ, et al
    Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.
    Histopathology. 2018 Mar 1. doi: 10.1111/his.13507.
    PubMed     Text format     Abstract available


    December 2017
  22. STALHAMMAR G, Robertson S, Wedlund L, Lippert M, et al
    Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
    Histopathology. 2017 Dec 8. doi: 10.1111/his.13452.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: